Advertisement
"This new role demonstrates the value we place on engaging creative anddynamic thinkers and I'm thrilled Dr. Covitz is joining our team," said SteveWest, President, MDS Nordion. "Acting as the primary scientific liaison, Dr.Covitz will advance our global innovation programs by identifyingopportunities, setting up collaborations, and driving ideas tocommercialization."
Advertisement
Dr. Covitz will report directly to Steve West, President of MDS Nordionand will be a member of the MDS Nordion Executive Management Team and arepresentative on the MDS Scientific Advisory Board.
Dr. Covitz comes to MDS Nordion from the National Cancer Institute (NCI)in Maryland, United States, where he held the position of Chief OperatingOfficer at the NCI's Center for Biomedical Informatics and InformationTechnology. He holds a Ph.D in Microbiology from Columbia University and aB.A. with a major in biology from Colgate University. Dr. Covitz holds anumber of patents and is widely published in scientific journals.
About MDS Nordion
MDS Nordion (www.mdsnordion.com) is a world leader in medical isotopes,radiation and related technologies. It is a business unit of MDS Inc.(TSX:MDS)(NYSE:MDZ). MDS is a global life sciences company that providesmarket-leading products and services our customers need for the development ofdrugs and diagnosis and treatment of disease. We are a leading global providerof pharmaceutical contract research, medical isotopes for molecular imaging,radiotherapeutics, and analytical instruments. MDS Inc. has more than 5,500highly skilled people in 29 countries. Find out more at www.mdsinc.com or bycalling 1-888-MDS-7222, 24 hours a day.
SOURCE MDS Nordion
